ATAI ATAI Life Sciences NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATAI

Price (delayed)

$4.52

Market cap

$1.66B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.82

Enterprise value

$1.62B

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 77
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 16
Highlights
The debt has dropped by 93% year-on-year and by 3.5% since the previous quarter
ATAI's EPS is up by 3.1% since the previous quarter
ATAI's quick ratio has surged by 143% year-on-year but it is down by 15% since the previous quarter
The company's gross profit has surged by 87% YoY but it fell by 15% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: FC UTI GHC

Key stats

What are the main financial stats of ATAI

ATAI stock price

How has the ATAI Life Sciences stock price performed over time
Intraday
-0.22%
1 week
2.49%
1 month
7.62%
1 year
83%
YTD
10.51%
QTD
27.68%

Financial performance

How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$3.49M
Gross profit
$3.49M
Operating income
-$635.75M
Net income
-$663.4M
Gross margin
100%
Net margin
-19,019.4%
The net margin has dropped by 138% year-on-year and by 18% since the previous quarter
The company's gross profit has surged by 87% YoY but it fell by 15% QoQ
ATAI Life Sciences's revenue has surged by 87% YoY but it has decreased by 15% QoQ
ATAI Life Sciences's operating margin has decreased by 19% from the previous quarter

Price vs fundamentals

How does ATAI's price correlate with its fundamentals

Growth

What is ATAI Life Sciences's growth rate over time

Valuation

What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
8.3
P/S
463.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
465.31
ATAI's EPS is up by 3.1% since the previous quarter
The P/B is 187% more than the 5-year quarterly average of 2.9 and 43% more than the last 4 quarters average of 5.8
The equity has increased by 31% year-on-year but it has declined by 10% since the previous quarter
ATAI Life Sciences's revenue has surged by 87% YoY but it has decreased by 15% QoQ
ATAI's P/S is 60% above its last 4 quarters average of 289.3 but 30% below its 5-year quarterly average of 664.5

Efficiency

How efficient is ATAI Life Sciences business performance
ATAI's ROS has dropped by 143% year-on-year and by 18% since the previous quarter
The company's return on invested capital rose by 7% QoQ
ATAI's ROA is up by 6% since the previous quarter
The company's return on equity rose by 6% QoQ

Dividends

What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATAI.

Financial health

How did ATAI Life Sciences financials performed over time
The current ratio has soared by 146% YoY but it has contracted by 15% from the previous quarter
ATAI's quick ratio has surged by 143% year-on-year but it is down by 15% since the previous quarter
The debt is 99% smaller than the equity
The company's debt to equity has shrunk by 94% YoY
The debt has dropped by 93% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.